{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:59:04Z","timestamp":1767650344136,"version":"build-2065373602"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","hpbonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["HPB"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.hpb.2019.07.011","type":"journal-article","created":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T11:17:15Z","timestamp":1567595835000},"page":"405-414","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center"],"prefix":"10.1016","volume":"22","author":[{"given":"Eva","family":"Roos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marin","family":"Strijker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lotte C.","family":"Franken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier R.","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanin E.","family":"van Hooft","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz-Josef","family":"Kl\u00fcmpen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanneke W.","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna W.","family":"Wilmink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Verheij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"van Gulik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc G.","family":"Besselink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hpb.2019.07.011_bib1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S0140-6736(05)67530-7","article-title":"Cholangiocarcinoma","volume":"366","author":"Khan","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.hpb.2019.07.011_bib2","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s11605-007-0282-0","article-title":"Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis","volume":"11","author":"Nathan","year":"2007","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2003.11.030","article-title":"Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase?","volume":"40","author":"Shaib","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2019.07.011_bib4","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.hpb.2019.07.011_bib5","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ng.2273","article-title":"Exome sequencing of liver fluke\u2013associated cholangiocarcinoma","volume":"44","author":"Ong","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.hpb.2019.07.011_bib6","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1093\/annonc\/mds077","article-title":"Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma","volume":"23","author":"van der Gaag","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2019.07.011_bib7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1245\/s10434-016-5531-6","article-title":"Development of a risk score to predict detection of metastasized or locally advanced perihilar cholangiocarcinoma at staging laparoscopy","volume":"23","author":"Coelen","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2019.07.011_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ejso.2010.11.008","article-title":"Multidisciplinary management of hilar cholangiocarcinoma (Klatskin tumor): extended resection is associated with improved survival","volume":"37","author":"van Gulik","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2019.07.011_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.hpb.2015.11.007","article-title":"External biliary drainage following major liver resection for perihilar cholangiocarcinoma: impact on development of liver failure and biliary leakage","volume":"18","author":"Olthof","year":"2016","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2019.07.011_bib10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/ng.3375","article-title":"Genomic spectra of biliary tract cancer","volume":"47","author":"Nakamura","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.hpb.2019.07.011_bib11","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1016\/j.hpb.2019.07.011_bib12","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.celrep.2017.02.033","article-title":"Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH -mutant molecular profiles","volume":"18","author":"Farshidfar","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.hpb.2019.07.011_bib13","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.hpb.2019.07.011_bib14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S1470-2045(15)00139-4","article-title":"Cediranib or placebo in combination with cisplatin and gemcitabine chemotherapy for patients with advanced biliary tract cancer (ABC-03): a randomised phase 2 trial","volume":"16","author":"Valle","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hpb.2019.07.011_bib15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/s12885-015-1498-0","article-title":"Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1 trial) - a randomized, multidisciplinary, multinational phase III trial","volume":"15","author":"Stein","year":"2015","journal-title":"BMC Canc"},{"key":"10.1016\/j.hpb.2019.07.011_bib16","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.hpb.2017.05.010","article-title":"Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis","volume":"19","author":"Ghidini","year":"2017","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2019.07.011_bib17","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/00000658-199610000-00005","article-title":"Cholangiocarcinoma","volume":"224","author":"Nakeeb","year":"1996","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib18","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.ejso.2015.05.013","article-title":"Intrahepatic, peri-hilar and distal cholangiocarcinoma: three different locations of the same tumor or three different tumors?","volume":"41","author":"Ercolani","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.hpb.2019.07.011_bib19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/s11605-011-1414-0","article-title":"Surgery for hilar cholangiocarcinoma: a multi-institutional update on practice and outcome by the AFC-HC study group","volume":"15","author":"Regimbeau","year":"2011","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib20","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.eururo.2014.11.025","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD Statement","volume":"67","author":"Collins","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.hpb.2019.07.011_bib21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00423-018-1649-2","article-title":"Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience","volume":"403","author":"Rassam","year":"2018","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib22","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/bjs.10452","article-title":"Recurrence after resection with curative intent for distal cholangiocarcinoma","volume":"104","author":"Komaya","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib23","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jamcollsurg.2015.09.005","article-title":"Recurrence rate and pattern of perihilar cholangiocarcinoma after curative intent resection","volume":"221","author":"Groot Koerkamp","year":"2015","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib24","first-page":"1114","article-title":"Perioperative and long-term outcome of intrahepatic cholangiocarcinoma involving the hepatic hilus after curative-intent resection: comparison with peripheral intrahepatic cholangiocarcinoma and hilar cholangiocarcinoma","volume":"163","author":"Zhang","year":"2018","journal-title":"Surg (United States)"},{"year":"2002","series-title":"AJCC cancer staging manual","author":"Greene","key":"10.1016\/j.hpb.2019.07.011_bib25"},{"key":"10.1016\/j.hpb.2019.07.011_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The Clavien-dindo classification of surgical complications","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib27","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1093\/annonc\/mdv106","article-title":"Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)","volume":"26","author":"Gourgou-Bourgade","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.hpb.2019.07.011_bib28","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","article-title":"Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma","volume":"234","author":"Jarnagin","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jamcollsurg.2016.03.035","article-title":"Postoperative mortality after liver resection for perihilar cholangiocarcinoma: development of a risk score and importance of biliary drainage of the future liver remnant","volume":"223","author":"Wiggers","year":"2016","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib30","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/SLA.0b013e3181e462e6","article-title":"Intrahepatic cholangiocarcinoma","volume":"252","author":"Ercolani","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib31","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1007\/s00534-009-0205-4","article-title":"Hilar cholangiocarcinoma: the memorial sloan-kettering cancer center experience","volume":"17","author":"Rocha","year":"2010","journal-title":"J\u00a0Hepatobiliary Pancreat Sci"},{"key":"10.1016\/j.hpb.2019.07.011_bib32","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.jamcollsurg.2017.06.007","article-title":"Postoperative liver failure risk score: identifying patients with resectable perihilar cholangiocarcinoma who can benefit from portal vein embolization","volume":"225","author":"Olthof","year":"2017","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib33","first-page":"583","article-title":"Recurrence rate and pattern of perihilar cholangiocarcinoma after curatiev intent resection","volume":"8","author":"Groot Koerkamp","year":"2016","journal-title":"J\u00a0Am Coll Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib34","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1365-2036.2011.04851.x","article-title":"Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer","volume":"34","author":"Skipworth","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.hpb.2019.07.011_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.hpb.2019.07.011_bib36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5604\/16652681.1226927","article-title":"Intrahepatic, perihilar and distal cholangiocarcinoma: management and outcomes","volume":"16","author":"David","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.hpb.2019.07.011_bib37","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.jhep.2011.12.010","article-title":"Assessment of pathology reports on hilar cholangiocarcinoma: the results of a nationwide, multicenter survey performed by the AFC-HC-2009 study group","volume":"56","author":"Chatelain","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.hpb.2019.07.011_bib38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/his.13520","article-title":"Data set for the reporting of intrahepatic cholangiocarcinoma, perihilar cholangiocarcinoma and hepatocellular carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)","volume":"73","author":"Burt","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.hpb.2019.07.011_bib39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000323825","article-title":"Extent of liver resection for hilar cholangiocarcinoma (Klatskin tumor): how much is enough?","volume":"28","author":"van Gulik","year":"2011","journal-title":"Dig Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib40","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.surg.2019.01.010","article-title":"Morbidity and mortality following major liver resection in patients with perihilar cholangiocarcinoma: a systematic review and meta-analysis","volume":"165","author":"Franken","year":"2019","journal-title":"Acceppted Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib41","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/00000658-199912000-00010","article-title":"Extended resections for hilar cholangiocarcinoma","volume":"230","author":"Neuhaus","year":"1999","journal-title":"Ann Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib42","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1245\/s10434-011-2077-5","article-title":"Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma","volume":"19","author":"Neuhaus","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2019.07.011_bib43","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00423-014-1210-x","article-title":"Curative-intent surgery for hilar cholangiocarcinoma: prognostic factors for clinical decision making","volume":"399","author":"Popescu","year":"2014","journal-title":"Langenbeck's Arch Surg"},{"key":"10.1016\/j.hpb.2019.07.011_bib44","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/ng.2806","article-title":"Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers","volume":"45","author":"Chan-On","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.hpb.2019.07.011_bib45","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.hpb.2018.02.640","article-title":"Variation in hospital mortality after pancreatoduodenectomy is related to failure to rescue rather than major complications: a nationwide audit","volume":"20","author":"van Rijssen","year":"2018","journal-title":"HPB"},{"key":"10.1016\/j.hpb.2019.07.011_bib46","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrc4017","article-title":"Functional and genetic deconstruction of the cellular origin in liver cancer","volume":"15","author":"Marquardt","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.hpb.2019.07.011_bib47","first-page":"1","article-title":"Stem\/progenitor cell niches involved in hepatic and biliary regeneration","volume":"2016","author":"Carpino","year":"2016","journal-title":"Stem Cell Int"},{"key":"10.1016\/j.hpb.2019.07.011_bib48","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/hep.25595","article-title":"Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes","volume":"55","author":"Komuta","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.hpb.2019.07.011_bib49","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1038\/sj.onc.1209558","article-title":"Liver stem cells and their implication in hepatocellular and cholangiocarcinoma","volume":"25","author":"Roskams","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.hpb.2019.07.011_bib50","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.1038\/ncomms7087","article-title":"Massive parallel sequencing uncovers actionable FGFR2\u2013PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma","volume":"6","author":"Sia","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.hpb.2019.07.011_bib51","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","article-title":"Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors","volume":"142","author":"Andersen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.hpb.2019.07.011_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccell.2015.12.012","article-title":"Genomic sequencing identifies ELF3 as a driver of ampullary carcinoma","volume":"29","author":"Yachida","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.hpb.2019.07.011_bib53","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1440-1827.2010.02543.x","article-title":"A\u00a0novel approach to biliary tract pathology based on similarities to pancreatic counterparts: is the biliary tract an incomplete pancreas?","volume":"60","author":"Nakanuma","year":"2010","journal-title":"Pathol Int"},{"key":"10.1016\/j.hpb.2019.07.011_bib54","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1245\/s10434-015-5046-6","article-title":"Cholangiocarcinoma heterogeneity revealed by multigene mutational profiling: clinical and prognostic relevance in surgically resected patients","volume":"23","author":"Ruzzenente","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.hpb.2019.07.011_bib55","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.18632\/oncotarget.1943","article-title":"Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups","volume":"5","author":"Simbolo","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.hpb.2019.07.011_bib56","doi-asserted-by":"crossref","first-page":"e16449","DOI":"10.1371\/journal.pone.0016449","article-title":"Gallbladder cancer predisposition: a multigenic approach to DNA-repair, apoptotic and inflammatory pathway genes","volume":"6","author":"Srivastava","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.hpb.2019.07.011_bib57","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1080\/13547500600648697","article-title":"Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility\u00a0to gallbladder cancer in North India","volume":"11","author":"Pandey","year":"2006","journal-title":"Biomarkers"},{"key":"10.1016\/j.hpb.2019.07.011_bib58","first-page":"19","article-title":"Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma","volume":"29","author":"Ooi","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.hpb.2019.07.011_bib59","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ng.3030","article-title":"Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway","volume":"46","author":"Li","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.hpb.2019.07.011_bib60","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.trecan.2016.07.008","article-title":"Colorectal cancer subtypes: developmental origin and microenvironmental regulation","volume":"2","author":"Fessler","year":"2016","journal-title":"Trends in Cancer"},{"key":"10.1016\/j.hpb.2019.07.011_bib61","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat Med"}],"container-title":["HPB"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X19306276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1365182X19306276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:26:44Z","timestamp":1761265604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1365182X19306276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1365182X19306276"],"URL":"https:\/\/doi.org\/10.1016\/j.hpb.2019.07.011","relation":{},"ISSN":["1365-182X"],"issn-type":[{"type":"print","value":"1365-182X"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center","name":"articletitle","label":"Article Title"},{"value":"HPB","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hpb.2019.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}